| dc.contributor.author | Sartor, O | |
| dc.contributor.author | de Bono, JS | |
| dc.date.accessioned | 2018-07-20T10:32:07Z | |
| dc.date.issued | 2018-02-15 | |
| dc.identifier.citation | NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 pp. 645 - 657 | |
| dc.identifier.issn | 0028-4793 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/2102 | |
| dc.identifier.eissn | 1533-4406 | |
| dc.identifier.doi | 10.1056/NEJMra1701695 | |
| dc.format.extent | 645 - 657 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.publisher | MASSACHUSETTS MEDICAL SOC | |
| dc.rights.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
| dc.title | Metastatic Prostate Cancer | |
| dc.type | Other | |
| rioxxterms.versionofrecord | 10.1056/NEJMra1701695 | |
| rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
| rioxxterms.licenseref.startdate | 2018-02-15 | |
| rioxxterms.type | Other | |
| dc.relation.isPartOf | NEW ENGLAND JOURNAL OF MEDICINE | |
| pubs.notes | affiliation: Sartor, O (Reprint Author), Tulane Canc Ctr, Box SL-42,1430 Tulane Ave, New Orleans, LA 70112 USA. Sartor, Oliver, Tulane Med Sch, New Orleans, LA USA. de Bono, Johann S., Inst Canc Res, London, England. de Bono, Johann S., Royal Marsden NHS Fdn Trust, London, England. keywords-plus: POST HOC ANALYSIS; ABIRATERONE ACETATE; PHASE-III; 1ST-LINE CHEMOTHERAPY; INCREASED SURVIVAL; PROGNOSTIC MODEL; PLUS PREDNISONE; CLINICAL-TRIAL; CASTRATION; ENZALUTAMIDE research-areas: General & Internal Medicine web-of-science-categories: Medicine, General & Internal author-email: [email protected] funding-acknowledgement: Bavarian Nordic; Oncogenex; Medivation; Pfizer; Myovant Sciences; Tokai; Astellas; Janssen; Endocyte and Advanced Accelerator Applications; EMD-Serono; Bayer; Sanofi; Cougar; Endocyte; Dendreon; PSMA Development; Eli Lilly; Merck; Innocrin; Genentech; AstraZeneca; GlaxoSmithKline; Sanofi-Aventis funding-text: Dr. Sartor reports receiving fees for serving as chair of the data management center and consulting fees from Bavarian Nordic, Oncogenex, Medivation, Pfizer, Myovant Sciences, Tokai, and Astellas, fees for serving as chair of the data management center, consulting fees, and travel support from Janssen, consulting fees from Endocyte and Advanced Accelerator Applications, consulting fees and travel support from Sanofi, Bayer, and EMD-Serono, and grant support from Bayer, Cougar, Endocyte, Dendreon, Tokai, Sanofi, PSMA Development, Eli Lilly, Merck, Innocrin, and Genentech; and Dr. de Bono, receiving grant support and advisory board fees from AstraZeneca, Genentech, GlaxoSmithKline, Janssen, Merck, and Pfizer, advisory board fees from Astellas and Bayer, grant support, advisory board fees, and provision of free drugs from Sanofi-Aventis, and being named as an inventor, with no financial interest, for patent 8,822,438. No other potential conflict of interest relevant to this article was reported. number-of-cited-references: 76 times-cited: 5 usage-count-last-180-days: 15 usage-count-since-2013: 15 journal-iso: N. Engl. J. Med. doc-delivery-number: FW0QK unique-id: ISI:000425000000010 da: 2018-07-20 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
| pubs.volume | 378 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Prostate Cancer Targeted Therapy Group | en_US |
| dc.contributor.icrauthor | De Bono, Johann | |
